Leonardo Drs, Inc. (DRS) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Leonardo Drs, Inc. (DRS) stock forecast summary
Our AI ranks Leonardo Drs, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Leonardo Drs, Inc. is a mid-cap company with a market capitalization of $9.38B. It ranks number 5 by market capitalization among the 10 Search, Detection, Navigation, Guidance, Aeronautical Sys issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for DRS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, DRS included.
Follow DRS freeDRS price chart and AI forecast
How DRS ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Leonardo Drs, Inc. (DRS) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Search, Detection, Navigation, Guidance, Aeronautical Sys peers listed below that report each metric.
Valuation & Market
| Metric | DRS | Rank |
|---|---|---|
| Market Cap | $9.38B | 5/10 |
| P/E Ratio | 29.14x | 2/6 |
| P/B Ratio | 3.35x | 5/9 |
| EPS | $1.15 | – |
| Book Value/Share | $10.50 | – |
| Revenue/Share | $14.16 | – |
| FCF/Share | $1.36 | – |
Profitability & Margins
| Metric | DRS | Rank |
|---|---|---|
| ROE | 11.5% | 3/9 |
| ROA | 7.7% | 3/10 |
| ROIC | 12.7% | 2/9 |
| Gross Margin | 24.9% | 7/8 |
| Operating Margin | 10.5% | 5/10 |
| Net Margin | 8.5% | 5/10 |
| EBT Margin | 10.3% | 5/10 |
| Tax Rate | 17.0% | – |
Financial Health
| Metric | DRS | Rank |
|---|---|---|
| Current Ratio | 1.92x | 6/10 |
| Quick Ratio | 1.56x | 4/8 |
| D/E Ratio | 0.50x | 4/9 |
| Financial Leverage | 1.50x | 4/9 |
| Interest Coverage | 8.6x | 2/8 |
| Working Capital | $975M | 5/10 |
Cash Flow
| Metric | DRS | Rank |
|---|---|---|
| Operating Cash Flow | $501M | 5/10 |
| Free Cash Flow | $363M | 5/10 |
| Capital Spending | -$138M | 7/10 |
| OCF Growth YoY | 49.1% | 2/7 |
| FCF Growth YoY | 54.5% | 2/7 |
| FCF/Sales | 9.6% | 5/9 |
| CapEx/Sales | 3.6% | 3/9 |
Operational Efficiency
| Metric | DRS | Rank |
|---|---|---|
| Asset Turnover | 0.90x | 2/9 |
| Receivables Turnover | 11.8x | 2/9 |
| Inventory Turnover | 7.4x | 2/6 |
| Fixed Assets Turnover | 7.2x | 4/8 |
| Days Sales Outstanding | 31 days | 8/9 |
| Days Inventory | 49 days | 5/6 |
| Payables Period | 23 days | 7/8 |
| Cash Conversion Cycle | 57 days | 5/6 |
Income Statement
| Metric | DRS | Rank |
|---|---|---|
| Total Revenue | $3.78B | 5/9 |
| Operating Income | $398M | 5/10 |
| Net Income | $322M | 5/10 |
| R&D Expense | $138M | 3/7 |
| Cost of Goods Sold | $2.84B | 4/8 |
Dividend & Shareholder Information
| Metric | DRS | Rank |
|---|---|---|
| Shares Outstanding | 267M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $2.04B | 48.6% of assets |
| Cash & Short-term Investments | $270M | 6.4% of assets |
| Accounts Receivable | $319M | 7.6% of assets |
| Inventory | $383M | 9.1% of assets |
| Total Liabilities | $1.39B | 33.2% of assets |
| Short-term Debt | $883M | 21.0% of assets |
DRS quarterly financials and insider trading
Leonardo Drs, Inc. (DRS) industry peers
Companies classified under the same SEC industry code as Leonardo Drs, Inc. (Search, Detection, Navigation, Guidance, Aeronautical Sys): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| DRS Leonardo Drs, Inc. | ▲ | $9.38B |
| NOC Northrop Grumman Corp /De/ | ▶ | $68.39B |
| GRMN Garmin Ltd | ▼ | $53.31B |
| LHX L3harris Technologies, Inc. /De/ | ▼ | $43.71B |
| TDY Teledyne Technologies Inc | ▼ | $28.33B |
| LUNR Intuitive Machines, Inc. | ▲ | $2.79B |
| NN Nextnav Inc. | ▲ | $1.91B |
| AERG Applied Energetics, Inc. | ▶ | $188M |
| CODA Coda Octopus Group, Inc. | ▲ | $113M |
| MIND Mind Technology, Inc | ▲ | $40M |
Where DRS sits on the market map
Leonardo Drs, Inc. (DRS) stock news
Loading...
Leonardo Drs, Inc. (DRS) stock forecast FAQ
What is the Leonardo Drs, Inc. (DRS) stock forecast?
Our AI ranks Leonardo Drs, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Leonardo Drs, Inc. stock predictions?
A per-ticker accuracy statistic for DRS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Leonardo Drs, Inc. forecasts updated?
Leonardo Drs, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Leonardo Drs, Inc.'s industry peers?
10 issuers in our coverage, DRS included, share the SEC industry code Search, Detection, Navigation, Guidance, Aeronautical Sys. The largest are: Northrop Grumman Corp /De/ (NOC), Garmin Ltd (GRMN), L3harris Technologies, Inc. /De/ (LHX), Teledyne Technologies Inc (TDY), Intuitive Machines, Inc. (LUNR), Nextnav Inc. (NN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.